DarioHealth Corp. (DRIO)

USD 0.65

(-9.08%)

Gross Profit Summary of DarioHealth Corp.

  • DarioHealth Corp.'s latest annual gross profit in 2023 was 5.98 Million USD , down -38.02% from previous year.
  • DarioHealth Corp.'s latest quarterly gross profit in 2024 Q2 was 2.75 Million USD , up 13.32% from previous quarter.
  • DarioHealth Corp. reported a annual gross profit of 9.65 Million USD in annual gross profit 2022, up 143.63% from previous year.
  • DarioHealth Corp. reported a annual gross profit of 3.96 Million USD in annual gross profit 2021, up 57.7% from previous year.
  • DarioHealth Corp. reported a quarterly gross profit of 2.43 Million USD for 2024 Q1, up 1742.42% from previous quarter.
  • DarioHealth Corp. reported a quarterly gross profit of 5.98 Million USD for 2023 FY, down -38.02% from previous quarter.

Annual Gross Profit Chart of DarioHealth Corp. (2023 - 2012)

Historical Annual Gross Profit of DarioHealth Corp. (2023 - 2012)

Year Gross Profit Gross Profit Growth
2023 5.98 Million USD -38.02%
2022 9.65 Million USD 143.63%
2021 3.96 Million USD 57.7%
2020 2.51 Million USD -3.23%
2019 2.59 Million USD 47.14%
2018 1.76 Million USD 34.63%
2017 1.31 Million USD 333.69%
2016 -561 Thousand USD 34.39%
2015 -855 Thousand USD 61.54%
2014 -2.22 Million USD 83.61%
2013 -13.56 Million USD 0.0%
2012 - USD 0.0%

Peer Gross Profit Comparison of DarioHealth Corp.

Name Gross Profit Gross Profit Difference
Bionano Genomics, Inc. 9.56 Million USD 37.445%
Prenetics Global Limited 8.82 Million USD 32.23%
Star Equity Holdings, Inc. 11.92 Million USD 49.824%
CareDx, Inc 178.32 Million USD 96.644%
Exact Sciences Corporation 1.84 Billion USD 99.676%
Exagen Inc. 29.45 Million USD 79.685%
Inotiv, Inc. 165.44 Million USD 96.383%
Guardant Health, Inc. 336.89 Million USD 98.224%
Biodesix, Inc. 36.07 Million USD 83.413%
BioNexus Gene Lab Corp. 1.32 Million USD -350.095%
Precipio, Inc. 6.01 Million USD 0.565%
iSpecimen Inc. 5.1 Million USD -17.151%
Natera, Inc. 492.74 Million USD 98.786%
Aspira Women's Health Inc. 5.26 Million USD -13.721%
Standard BioTools Inc. 50.45 Million USD 88.139%
23andMe Holding Co. 99.37 Million USD 93.978%
Castle Biosciences, Inc. 174.8 Million USD 96.577%
Personalis, Inc. 18.2 Million USD 67.135%
Aclaris Therapeutics, Inc. 13.16 Million USD 54.557%
Applied DNA Sciences, Inc. 5.53 Million USD -8.143%
OpGen, Inc. -90.69 Thousand USD 6698.011%
T2 Biosystems, Inc. -8.17 Million USD 173.244%
Myriad Genetics, Inc. 476.4 Million USD 98.744%
ICON Public Limited Company 1.81 Billion USD 99.67%
NeoGenomics, Inc. 244.6 Million USD 97.554%
Star Equity Holdings, Inc. 11.92 Million USD 49.824%
IDEXX Laboratories, Inc. 2.18 Billion USD 99.727%
RadNet, Inc. 93 Million USD 93.566%
MDxHealth SA 43.92 Million USD 86.378%
Psychemedics Corporation 8.41 Million USD 28.872%
Illumina, Inc. 2.74 Billion USD 99.782%
Check-Cap Ltd. -212 Thousand USD 2922.642%
Twist Bioscience Corporation 133.34 Million USD 95.513%
Fulgent Genetics, Inc. 104.45 Million USD 94.271%
Sera Prognostics, Inc. 96 Thousand USD -6133.333%
ENDRA Life Sciences Inc. -275.45 Thousand USD 2272.437%
OPKO Health, Inc. 318.12 Million USD 98.119%
Medpace Holdings, Inc. 524.5 Million USD 98.859%
Neogen Corporation 463.9 Million USD 98.71%
Intelligent Bio Solutions Inc. 1.42 Million USD -319.745%
Prenetics Global Limited 8.82 Million USD 32.23%
Mainz Biomed B.V. 509.65 Thousand USD -1074.118%
bioAffinity Technologies, Inc. 791.61 Thousand USD -655.923%
Trinity Biotech plc 19.45 Million USD 69.234%
Neuronetics, Inc. 51.7 Million USD 88.427%
Sotera Health Company 577.15 Million USD 98.963%
bioAffinity Technologies, Inc. 791.61 Thousand USD -655.923%